TBPH icon

Theravance Biopharma

84 hedge funds and large institutions have $1.31B invested in Theravance Biopharma in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 11 closing their positions.

Holders
84
Holders Change
Holders Change %
0%
% of All Funds
1.91%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
11
Increased
30
Reduced
25
Closed
11
Calls
$2K
Puts
$944K
Net Calls
-$942K
Net Calls Change
+$851K
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
76
Tower Research Capital (TRC)
New York
$15K 546 -6,108 -92%
Citigroup
77
Citigroup
New York
$10K 358 -9,334 -96%
Envestnet Asset Management
78
Envestnet Asset Management
Illinois
$9K 323 +26 +9%
PA
79
Parallel Advisors
California
$5K 193
IA
80
IFP Advisors
Florida
$2K 57
PNC Financial Services Group
81
PNC Financial Services Group
Pennsylvania
$2K 36 +36 New
LFA
82
Legacy Financial Advisors
Kentucky
$2K 94 +94 New
OM
83
Opaleye Management
Massachusetts
-180,000 Closed
American Century Companies
84
American Century Companies
Missouri
-28,279 Closed
NFA
85
Nationwide Fund Advisors
Ohio
-23,161 Closed
First Trust Advisors
86
First Trust Advisors
Illinois
-21,118 Closed
CS
87
Candriam SCA
Luxembourg
-20,000 Closed
Russell Investments Group
88
Russell Investments Group
United Kingdom
-18,508 Closed
B
89
Barings
North Carolina
-11,800 Closed
SG Americas Securities
90
SG Americas Securities
New York
-9,061 Closed
V
91
Veritable
Delaware
-6,889 Closed
Group One Trading
92
Group One Trading
Illinois
-3,500 Closed
Simplex Trading
93
Simplex Trading
Illinois
-1,177 Closed
HCM
94
Highbridge Capital Management
New York
Wolverine Trading
95
Wolverine Trading
Illinois
SEI Investments
96
SEI Investments
Pennsylvania
$0 8
LYV
97
Live Your Vision
Pennsylvania
LTFS
98
Ladenburg Thalmann Financial Services
Florida
$0 17